CrossRef Gender-specific abdominal fat distribution and insulin resistance associated with organophosphate esters and phthalate metabolites exposure Xiaoliu Shi, Wanyue Wang, Jiafan Feng, Xiaochun Ma, Mengting Xu, Cui Wang Environmental Pollution.2024
In this case, continuing the supplement is unlikely to produce better results, and switching to a proven pharmaceutical option may be more effective
Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights including variants in FTO , GLP1R , and MC4R that shape your baseline GLP-1, appetite-regulation, and energy-balance biology
Now, my listeners, for the most part are women in perimenopause and menopause, which I would imagine many from your community are as well
phase 3 trials ongoing as of 2025 Best phase 2 weight loss (retatrutide) / 24.2% at 48 weeks, 12 mg dose Best phase 3 weight loss (tirzepatide) / 22.5% at 72 weeks, 15 mg dose Combination evidence / zero published controlled trials Primary combination risk / additive nausea, vomiting, potential pancreatitis Switching rationale / inadequate response or tolerability on tirzepatide Guideline position on combining / no major guideline endorses dual-incretin stacking What Are Mounjaro and Retatrutide, and How Do They Differ